ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print September 13, 2006, 10.1183/09031936.00149005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rytilä, P.
Right arrow Articles by Djukanovic, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rytilä, P.
Right arrow Articles by Djukanovic, R.
Eur Respir J 2006; 28:1163-1169
Copyright ©ERS Journals Ltd 2006

Airway neutrophilia in COPD is not associated with increased neutrophil survival

P. Rytilä1,2, M. Plataki1, F. Bucchieri1, M. Uddin1, G. Nong1, V. L. Kinnula3 and R. Djukanovic1

1 Division of Infection, Inflammation and Repair, University of Southampton, Southampton, UK, 2 Division of Allergy, and 3 Division of Respiratory Diseases, Dept of Medicine, Helsinki University Central Hospital, Helsinki, Finland.

CORRESPONDENCE: P. Rytilä, Skin and Allergy Hospital, Helsinki University Central Hospital, Post Box 160, 00029 HUCH, Helsinki, Finland. Fax: 358 947186500. E-mail: paula.rytila{at}hus.fi

Keywords: Apoptosis, chronic obstructive pulmonary disease, inflammation, neutrophils

Received: December 19, 2005
Accepted August 4, 2006

Neutrophilic airway inflammation is a prominent feature of chronic obstructive pulmonary disease (COPD) and correlates with disease severity. The mechanisms that determine the extent of neutrophilia could involve increased influx or prolonged survival of neutrophils. The aim of the study was to assess whether neutrophil pro-survival mechanisms are increased in the airways of subjects with COPD owing to the presence of anti-apoptotic factors in the bronchial lining fluid.

Induced sputum samples were collected from 20 subjects with stable COPD, 14 healthy smokers and 14 healthy controls. Quantification of apoptotic neutrophils was based on typical morphological cell changes. Anti-apoptotic, pro-survival activity in the sputum was studied by culturing peripheral blood neutrophils with the fluid phase of induced sputum. Apoptosis was assessed both by morphology and flow cytometry using Annexin V/7-aminoactinomycin D staining.

COPD patients and healthy smokers had significantly higher percentages of sputum neutrophils than healthy controls. However, there were no significant differences between the three subject groups in either the proportion of apoptotic neutrophils in sputum or the in vitro anti-apoptotic activity detected in the sputum fluid phase.

In conclusion, prolonged survival of neutrophils in sputum is not a feature of chronic obstructive pulmonary disease and cannot explain the increased numbers of airway neutrophils in this disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.